DisGeNET

DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.

Source Last Updated
DisGeNET July 29, 2024
Displaying entries 61201 - 61225 of 62743 in total
Disease ID Disease Name Gene Symbol Gene ID ▼ Gene Name UniProt ID
C0270914 Hereditary Motor and Sensory-Neuropathy Type II SPTLC1 10558 serine palmitoyltransferase long chain base subunit 1 O15269
C0037268 Skin Abnormalities SPTLC1 10558 serine palmitoyltransferase long chain base subunit 1 O15269
C0027888 Hereditary Motor and Sensory Neuropathies SPTLC1 10558 serine palmitoyltransferase long chain base subunit 1 O15269
C0022593 Keratosis SPTLC1 10558 serine palmitoyltransferase long chain base subunit 1 O15269
C0007134 Renal Cell Carcinoma SPTLC1 10558 serine palmitoyltransferase long chain base subunit 1 O15269
C1145628 Autonomic nervous system disorders SPTLC1 10558 serine palmitoyltransferase long chain base subunit 1 O15269
C0011860 Diabetes Mellitus, Non-Insulin-Dependent SPTLC1 10558 serine palmitoyltransferase long chain base subunit 1 O15269
C0020179 Huntington Disease SPTLC1 10558 serine palmitoyltransferase long chain base subunit 1 O15269
C0524851 Neurodegenerative Disorders SPTLC1 10558 serine palmitoyltransferase long chain base subunit 1 O15269
C0006142 Malignant neoplasm of breast SPTLC1 10558 serine palmitoyltransferase long chain base subunit 1 O15269
C0017638 Glioma SPTLC1 10558 serine palmitoyltransferase long chain base subunit 1 O15269
C0023473 Myeloid Leukemia, Chronic AGPAT2 10555 1-acylglycerol-3-phosphate O-acyltransferase 2 O15120
C0023787 Lipodystrophy AGPAT2 10555 1-acylglycerol-3-phosphate O-acyltransferase 2 O15120
C0029463 Osteosarcoma AGPAT2 10555 1-acylglycerol-3-phosphate O-acyltransferase 2 O15120
C0158981 Neonatal diabetes mellitus AGPAT2 10555 1-acylglycerol-3-phosphate O-acyltransferase 2 O15120
C1720863 Congenital Generalized Lipodystrophy Type 2 AGPAT2 10555 1-acylglycerol-3-phosphate O-acyltransferase 2 O15120
C1720862 Congenital Generalized Lipodystrophy Type 1 AGPAT2 10555 1-acylglycerol-3-phosphate O-acyltransferase 2 O15120
C0027051 Myocardial Infarction AGPAT2 10555 1-acylglycerol-3-phosphate O-acyltransferase 2 O15120
C1531647 Cerebral ventriculomegaly AGPAT2 10555 1-acylglycerol-3-phosphate O-acyltransferase 2 O15120
C0018802 Congestive heart failure AGPAT2 10555 1-acylglycerol-3-phosphate O-acyltransferase 2 O15120
C0494360 Lipodystrophy, not elsewhere classified AGPAT2 10555 1-acylglycerol-3-phosphate O-acyltransferase 2 O15120
C1306459 Primary malignant neoplasm AGPAT2 10555 1-acylglycerol-3-phosphate O-acyltransferase 2 O15120
C3714756 Intellectual Disability AGPAT2 10555 1-acylglycerol-3-phosphate O-acyltransferase 2 O15120
C0023487 Acute Promyelocytic Leukemia AGPAT2 10555 1-acylglycerol-3-phosphate O-acyltransferase 2 O15120
C0036439 Scoliosis, unspecified AGPAT2 10555 1-acylglycerol-3-phosphate O-acyltransferase 2 O15120

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024